Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

Newer Lipid therapy Guidelines – Role of PCSK9 Inhibitors in ACS

Presentation TCT India 2025

Newer Lipid therapy Guidelines – Role of PCSK9 Inhibitors in ACS

Presenter: M. Srinivasa Rao

July 26, 2025

Optimal LDL levels in patients with ACS undergoing PCI

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.